BIOLOGICAL TOLERANCE OF LOGIPARIN, A LOW-MOLECULAR-WEIGHT HEPARIN USED IN PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT

被引：0

作者：

CHRISTIANSEN, HM ^{[1
]}

RUDLASSEN, M ^{[1
]}

BORRIS, LC ^{[1
]}

SORENSEN, JV ^{[1
]}

SCHMIDT, K ^{[1
]}

BOLL, KL ^{[1
]}

EISKJAER, S ^{[1
]}

NIELSEN, BW ^{[1
]}

LUCHT, U ^{[1
]}

机构：

[1] AARHUS KOMMUNE HOSP,DEPT ORTHOPED,DK-8000 AARHUS,DENMARK

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1991年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：224 / 227

页数：4

共 50 条

[41] TEACHING OF PATIENTS UNDERGOING TOTAL HIP-REPLACEMENT SURGERY
SANTAVIRTA, N
LILLQVIST, G
SARVIMAKI, A
HONKANEN, V
KONTTINEN, YT
SANTAVIRTA, S
INTERNATIONAL JOURNAL OF NURSING STUDIES, 1994, 31 (02) : 135 - 142
[42] CITATION-CLASSIC - COMPARISON OF WARFARIN, LOW-MOLECULAR-WEIGHT DEXTRAN, ASPIRIN, AND SUBCUTANEOUS HEPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP-REPLACEMENT
HARRIS, WH
CURRENT CONTENTS/CLINICAL MEDICINE, 1987, (19) : 14 - 14
[43] RELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS OF TINZAPARIN (LOGIPARIN), A LOW-MOLECULAR-WEIGHT HEPARIN, IN DOGS
BRINDLEY, CJ
TAYLOR, T
DINESS, V
OESTERGAARD, PB
CHASSEAUD, LF
XENOBIOTICA, 1993, 23 (06) : 575 - 588
[44] Dosing and timing of low-molecular-weight heparin thromboprophylaxis in total hip arthroplasty
Colwell, CW
ORTHOPEDICS, 2003, 26 (11) : 1155 - 1161
[45] Aspirin Versus Low-Molecular-Weight Heparin After Total Hip Arthroplasty
Granziera, Serena
Cohen, Alexander T.
ANNALS OF INTERNAL MEDICINE, 2013, 159 (07) : 502 - 502
[46] A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement
Eriksson, BI
WilleJorgensen, P
Kalebo, P
Mouret, P
Rosencher, N
Bosch, P
Baur, M
Ekman, S
Bach, D
Lindbratt, S
Close, P
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19): : 1329 - 1335
[47] Recombinant hirudin compared with low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement
Robb, J
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13): : 920 - 920
[48] LIPOLYTIC EFFECT OF LOW-MOLECULAR-WEIGHT-HEPARIN (FRAGMIN(R)) AND HEPARIN DIHYDROERGOTAMINE IN THROMBOPROPHYLACTIC DOSES DURING TOTAL HIP-REPLACEMENT
MYRMEL, T
LARSEN, TS
REIKERAS, O
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1992, 52 (07): : 741 - 745
[49] PLASMA HEPARIN LEVELS AFTER LOW-DOSE SUBCUTANEOUS HEPARIN IN PATIENTS UNDERGOING HIP-REPLACEMENT
BROZOVIC, M
STIRLING, Y
ABBOSH, J
BRITISH JOURNAL OF HAEMATOLOGY, 1975, 31 (04) : 461 - 466
[50] COMPARISON OF THE EFFICACY AND COST OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND STANDARD HEPARIN (SH) FOR THE PREVENTION OF DEEP-VEIN THROMBOSIS (DVT) FOLLOWING TOTAL HIP-REPLACEMENT (THR)
ANDERSON, DR
OBRIEN, B
LEVINE, MN
HIRSH, J
THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 650 - 650

← 1 2 3 4 5 →